NOVOZYMES A/S SPONS.ADR 1 (NZM) — Net Asset Momentum
NOVOZYMES A/S SPONS.ADR 1 (NZM) recorded a net asset momentum of -2.9% as of December 2025, with net assets of €10.86 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See NOVOZYMES A/S SPONS.ADR 1 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
NOVOZYMES A/S SPONS.ADR 1 Net Asset Momentum (2021–2025)
This chart tracks NOVOZYMES A/S SPONS.ADR 1's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -2.9%, with net assets of €10.86 Billion EUR as of December 2025. Read NOVOZYMES A/S SPONS.ADR 1 (NZM) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
The table below shows the complete annual net asset history for NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see NOVOZYMES A/S SPONS.ADR 1 (NZM) market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €10.86 Billion | €16.35 Billion | €5.49 Billion | ▼ -2.9% |
| 2024 | €11.18 Billion | €15.20 Billion | €4.02 Billion | ▲ +480.4% |
| 2023 | €1.93 Billion | €3.81 Billion | €1.88 Billion | ▲ +0.8% |
| 2022 | €1.91 Billion | €3.76 Billion | €1.85 Billion | ▲ +16.4% |
| 2021 | €1.64 Billion | €3.33 Billion | €1.69 Billion | — |